<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Based on previous in-vitro characterization studies, an EPL-NE liquisolid tablet formulation that showed good flow and compression properties and a high drug release rate were selected and subjected to further solid-state characterization and bioavailability studies.</p>
